In some primary tumours, such as colon adenocarcinoma or lymphoma, tumour-derived NO promotes tumour progression [34, 35], primarily through an up-regulation of iNOS leading to a more proliferative and invasive tumour phenotype due to impairment of p53-induced apoptosis [35, 36]. The gene discussed is TP53; the disease is colon adenocarcinoma.